Allurion secures new patent for gastric balloon technology
NATICK, Mass. - Allurion Technologies, Inc. (NYSE: ALUR), a company focused on obesity treatment solutions, has expanded its ...
Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs
Key Takeaways Allurion Technologies said it planned to test its gastric balloon with the key ingredient in popular ...
MarketWatch7d
Allurion Shares Rise 68% After Weight Loss Study News
Allurion added previous studies of patients treated with the Allurion Balloon in combination with the Allurion Virtual Care Suite demonstrated outcomes in which patients lose weight while ...
Yahoo Finance7d
Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program
1 In contrast, in previous studies, patients treated with the Allurion Balloon in combination with the Allurion Virtual Care Suite have demonstrated strong patient outcomes in which patients lose ...
Seeking Alpha7d
Allurion stock soars 70% on weight-loss therapy update
Shares of Allurion (NYSE:ALUR) soared 70% in post-market trading Thursday after ending the regular session 21% higher on news the company plans to conduct a clinical study of its gastric balloon ...